tiprankstipranks
DMCC Speciality Chemicals Limited (IN:DMCC)
:DMCC
India Market
Want to see IN:DMCC full AI Analyst Report?

DMCC Speciality Chemicals Limited (DMCC) AI Stock Analysis

0 Followers

Top Page

IN:DMCC

DMCC Speciality Chemicals Limited

(DMCC)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
₹259.00
▲(2.82% Upside)
Action:Reiterated
Date:05/20/26
The score is held back primarily by weak FY2026 cash flow (negative operating and free cash flow) despite a reasonably solid balance sheet and recovering revenue/earnings. Support comes from favorable technical momentum (price above major moving averages with positive MACD). Valuation is acceptable but not especially compelling given the low dividend yield.
Positive Factors
Revenue Recovery
A clear revenue rebound in FY2026 demonstrates demand resilience and that end markets are recovering. Durable top-line growth reduces reliance on cost cuts, supports capacity utilization and gives management scope to reinvest in product lines or working capital, aiding medium‑term stability.
Negative Factors
Negative Cash Flow
A shift to negative operating and free cash flow weakens internal funding, forcing reliance on external financing or equity to fund capex and working capital. This undermines capital flexibility, raises execution risk, and can constrain investments or dividend policy until cash conversion normalizes.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery
A clear revenue rebound in FY2026 demonstrates demand resilience and that end markets are recovering. Durable top-line growth reduces reliance on cost cuts, supports capacity utilization and gives management scope to reinvest in product lines or working capital, aiding medium‑term stability.
Read all positive factors

DMCC Speciality Chemicals Limited (DMCC) vs. iShares MSCI India ETF (INDA)

DMCC Speciality Chemicals Limited Business Overview & Revenue Model

Company Description
DMCC Speciality Chemicals Limited, alongside its affiliated entities, operates as a manufacturer and global supplier of both specialty and commodity chemicals. Its distribution network spans both domestic Indian markets and international territori...
How the Company Makes Money
null...

DMCC Speciality Chemicals Limited Financial Statement Overview

Summary
Income statement and balance sheet are moderate (revenue rebound in FY2026 and manageable leverage), but cash flow quality is a major weakness with FY2026 operating and free cash flow turning negative, increasing execution and funding-risk concerns.
Income Statement
62
Positive
Balance Sheet
68
Positive
Cash Flow
34
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue4.96B5.82B4.31B3.26B3.85B3.25B
Gross Profit1.49B935.49M1.33B1.14B1.37B1.28B
EBITDA649.42M632.95M570.16M366.94M387.81M467.11M
Net Income278.50M273.29M215.28M115.89M69.31M213.40M
Balance Sheet
Total Assets3.75B4.46B3.80B3.77B4.01B3.84B
Cash, Cash Equivalents and Short-Term Investments27.00M44.55M51.52M70.63M33.50M29.59M
Total Debt395.59M865.32M470.70M877.11M1.01B933.99M
Total Liabilities1.41B1.97B1.53B1.68B2.03B1.90B
Stockholders Equity2.34B2.48B2.28B2.10B1.98B1.94B
Cash Flow
Free Cash Flow170.43M-330.45M310.28M194.33M79.75M-480.71M
Operating Cash Flow174.18M-270.57M380.41M383.74M298.81M506.56M
Investing Cash Flow-12.05M-69.76M-66.82M-100.42M-205.59M-984.14M
Financing Cash Flow-199.02M318.06M-297.83M-271.01M-99.94M461.07M

DMCC Speciality Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price251.90
Price Trends
50DMA
270.60
Negative
100DMA
247.71
Positive
200DMA
266.90
Negative
Market Momentum
MACD
-8.11
Positive
RSI
46.51
Neutral
STOCH
54.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DMCC, the sentiment is Neutral. The current price of 251.9 is below the 20-day moving average (MA) of 262.49, below the 50-day MA of 270.60, and below the 200-day MA of 266.90, indicating a bearish trend. The MACD of -8.11 indicates Positive momentum. The RSI at 46.51 is Neutral, neither overbought nor oversold. The STOCH value of 54.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:DMCC.

DMCC Speciality Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₹12.00B23.610.38%22.93%18.28%
71
Outperform
₹7.18B29.8815.71%-3.48%
66
Neutral
₹2.15B17.011.11%-39.14%-65.08%
64
Neutral
₹1.28B39.3910.99%
62
Neutral
₹6.37B23.570.97%34.84%26.96%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
43
Neutral
₹1.13B-4.42191.08%-1160.38%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DMCC
DMCC Speciality Chemicals Limited
257.75
-7.76
-2.92%
IN:CHEMBOND
Chembond Chemicals Limited
163.00
-78.12
-32.40%
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
193.05
2.60
1.37%
IN:INDOBORAX
Indo Borax & Chemicals Limited
367.05
176.25
92.37%
IN:OCCL
Oriental Carbon & Chemicals Ltd
130.60
-128.75
-49.64%
IN:REGENCERAM
Regency Ceramics Ltd
38.65
-9.61
-19.91%

DMCC Speciality Chemicals Limited Corporate Events

DMCC Speciality Chemicals Publishes Q4 FY26 Earnings Call Transcript
May 25, 2026
DMCC Speciality Chemicals Limited has released the official transcript of its Q4 FY26 earnings conference call with investors and analysts, held on May 19, 2026, to discuss the company’s financial performance. The document, filed with Indian...
DMCC faces Rs 2.48 crore cargo-handling suit from Shipping Corporation of India
Mar 23, 2026
DMCC Speciality Chemicals Limited has disclosed that the Shipping Corporation of India Limited has filed a commercial suit against the company in the City Civil Court, Mumbai. The dispute relates to charges for cleaning, stowing, restowing and res...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 20, 2026